Norden Group LLC purchased a new stake in Novanta Inc. (NASDAQ:NOVT – Free Report) during the fourth quarter, HoldingsChannel.com reports. The firm purchased 1,768 shares of the technology company’s stock, valued at approximately $298,000.
Other institutional investors have also recently modified their holdings of the company. Operose Advisors LLC acquired a new position in Novanta during the third quarter worth about $34,000. Fifth Third Bancorp boosted its stake in shares of Novanta by 16.7% during the 3rd quarter. Fifth Third Bancorp now owns 721 shares of the technology company’s stock worth $103,000 after acquiring an additional 103 shares in the last quarter. Revolve Wealth Partners LLC acquired a new stake in shares of Novanta in the 4th quarter worth approximately $206,000. OneAscent Financial Services LLC purchased a new position in Novanta in the 4th quarter valued at approximately $206,000. Finally, Alliance Wealth Advisors LLC UT purchased a new position in Novanta in the 4th quarter valued at approximately $217,000. 98.35% of the stock is currently owned by hedge funds and other institutional investors.
Novanta Stock Up 0.2 %
NOVT opened at $156.78 on Thursday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.91 and a current ratio of 2.98. The company has a market cap of $5.62 billion, a price-to-earnings ratio of 77.23 and a beta of 1.35. Novanta Inc. has a one year low of $111.20 and a one year high of $187.60. The business’s fifty day moving average is $166.76 and its two-hundred day moving average is $156.84.
Insider Buying and Selling at Novanta
In other news, CEO Matthijs Glastra sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $172.00, for a total transaction of $860,000.00. Following the completion of the transaction, the chief executive officer now directly owns 24,572 shares of the company’s stock, valued at approximately $4,226,384. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In related news, CFO Robert Buckley sold 3,000 shares of the business’s stock in a transaction dated Thursday, February 29th. The shares were sold at an average price of $170.40, for a total value of $511,200.00. Following the completion of the transaction, the chief financial officer now owns 120,419 shares of the company’s stock, valued at approximately $20,519,397.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Matthijs Glastra sold 5,000 shares of the company’s stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $172.00, for a total transaction of $860,000.00. Following the completion of the transaction, the chief executive officer now owns 24,572 shares in the company, valued at $4,226,384. The disclosure for this sale can be found here. Insiders have sold 9,500 shares of company stock valued at $1,611,545 over the last quarter. Corporate insiders own 1.20% of the company’s stock.
Novanta Company Profile
Novanta Inc, together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation.
Featured Stories
- Five stocks we like better than Novanta
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Yum! Brands: Can Digital Strength Offset Same-Store Declines?
- What is Insider Trading? What You Can Learn from Insider Trading
- Wall Street Believes in First Solar Stock’s Bull Cycle
- What is the Hang Seng index?
- AMD is Down 35%. Now is the Time to Buy the Dip
Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT – Free Report).
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.